Inhibition of ATGL by Atglistatin reverses the ATGL-induced tumorigenesis via downregulation of the genes involved in stem cell function, mitochondrial function, and lipid metabolism in colon cancer stem cells [82]. This evidence concerns the gene PNPLA2 and colonic neoplasm.